CanadianCannabisWire
CanadianCannabisWire

News and Publishing Service for
Cannabis Related, Canadian Companies

CanadianCannabisWire LimeLight of The MONTH is
 

InMed Pharmaceuticals Inc.
(NASDAQ: INM)

View The Complete Profile

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a global leader in the development, manufacture and commercialization of rare cannabinoids for pharmaceutical and consumer health and wellness applications. InMed is a clinical stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids.

The company is dedicated to delivering new therapeutic alternatives to treat conditions with high unmet medical needs. The company is also developing a proprietary manufacturing technology to produce pharmaceutical-grade rare cannabinoids in the lab.

In October 2021, InMed announced its acquisition of BayMedica Inc., a private U.S. firm specializing in the manufacture and commercialization of rare cannabinoids for the health and wellness sector. BayMedica, now operating as a subsidiary of InMed, is a revenue-stage biotechnology firm leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications.

Investment Considerations

  • InMed has a world class leadership team with a successful track record of drug development and commercialization.
  • InMed has a solid and expanding intellectual property portfolio with multiple patents filed.
  • The company recently acquired rare cannabinoids manufacturer BayMedica.
  • InMed retains all commercial rights to its IntegraSyn manufacturing system.
  • InMed has commenced a Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa.
  • The consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to $25 billion by 2025 and to $50 billion by 2029.
View More





Recent Coverage

InvestorNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has closed on a private placement with two healthcare-focused institutional investors. The placement included the sale of 1,818,185 INM common shares, which were issued at a purchase price of $3.30 per share (or prefunded warrant in lieu thereof); the shares were priced at-the-market under NASDAQ rules. The announcement also noted that InMed issued unregistered preferred investment options to the investors in the offering to purchase up to 3,272,733 common shares. The offering resulted in approximately $6 million in gross proceeds for the company, which plans to use the funds to continue pipeline development of its pharmaceutical drug candidates as well as advance manufacturing know-how of cannabinoids and cannabinoid analogs; the company may also use portions of the proceeds to support intellectual property development and other commercial activities and for general working capital purposes. According to the announcement, H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

To view the full source article, visit: https://ibn.fm/DLaPd

Receive SMS Text Alerts from CanadianCannabisWire

Text "CCWIRE" to 844-397-5787

(US Mobile Phones Only)

Featured Event
 

The Lift & Co. Expo
January 12-14, 2022 - Vancouver, BC

The Lift & Co. Expo invites businesses, growers, patients, and leaders of the cannabis community to its Lift& Co. Expo Vancouver on January 12-14, 2023. The Canadian community participates in the Lift& Co Expo in growing numbers as the event offers immense networking opportunities and valuable education on the latest topics that buzz in the cannabis industry.

Thought leaders and industry veterans will preside as speakers offering insights about important industry trends and technology, and introducing the latest businesses and products. Capital investors can explore the potential of new products to establish a hold over the cannabis market before other vendors do.

The Cannabis Business Conference will be attended by cannabis dignitaries who will discuss a range of important topics, and offer presentations on the latest issues and trends in Canada’s cannabis industry.

Connect with the industry leaders, experts, innovators, regulators, and enthusiasts of the cannabis business community at North America’s leading cannabis conference and trade show in Vancouver.

To know more, please visit https://ibn.fm/J28rO

Conference Highlights

  • The Canadian cannabis community and enthusiasts worldwide are invited to attend its Lift& Co. Expo Vancouver on January 12-14, 2023
  • The Lift Business Conference is an additional part of the 3-day Lift & Co. Expo 2022 that is being held at the Vancouver Convention Centre
  • Exhibitors will showcase unique cannabis products and ideas at their booths where investors can discover potential investment ideas
View Event


Upcoming Events

View All Events

About CanadianCannabisWire (CNW)

CanadianCannabisWire (CCW) is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging a professional team of journalists and writers, CCW introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network of over 5,000 key distribution outlets. Cutting through information overload, CCW's innovative and proprietary systems clearly and succinctly deliver its clients much needed visibility, recognition and brand awareness. CCW is where news, content and information converge.

Please see full terms of use and disclaimers on the CanadianCannabisWire website
applicable to all content provided by CanadianCannabisWire, wherever published or re-published: https://www.canadiancannabiswire.com/disclaimer/

Stay Informed
Bookmark the CCW newsroom page in your favorite browser to stay up to date on all the latest Canadian cannabis news.

See The Latest

Connect With Us
Follow us on social media for the latest news and information from our network of brands and clients.

follow us on twitter  meet on linkedin  like us on facebook

CanadianCannabisWire

CanadianCannabisWire
40 King Street West, Suite 1700-CNW, Toronto, ON M5H 3Y2 (905) 674-5977


Copyright © 2019. All Rights Reserved.

-->